Executive Summary
Global Drugs and Vaccines Market
Product Overview
Market Definition
Segmentation
Assumptions and Acronyms
Research Methodology
Research Objectives
Primary Research
Secondary Research
Forecast Model
Market Size Estimation
Average Pricing Analysis
Macro-Economic Indicators
Market Dynamics
Growth Drivers
Restraints
Opportunities
Trends
Correlation & Regression Analysis
Correlation Matrix
Regression Matrix
Recent Developments, Policies & Regulatory Landscape
Risk Analysis
Demand Risk Analysis
Supply Risk Analysis
Porter’s Five Forces Analysis
Threat of New Entrants
Bargaining Power of Suppliers
Threat of Substitutes
Industry Rivalry
PEST Analysis
Political
Economic
Social
Technological
By Value (USD Million), 2020–2030F
Y-o-Y Growth (%), 2021–2030F
By Type: Market Share (2020–2030F)
Vaccines, By Value (USD Million), 2020–2030F; Y-o-Y Growth (%) 2021–2030F
Drugs, By Value (USD Million), 2020–2030F; Y-o-Y Growth (%) 2021–2030F
By End-User: Market Share (2020–2030F)
Hospitals, By Value (USD Million), 2020–2030F; Y-o-Y Growth (%) 2021–2030F
Clinics, By Value (USD Million), 2020–2030F; Y-o-Y Growth (%) 2021–2030F
Others, By Value (USD Million), 2020–2030F; Y-o-Y Growth (%) 2021–2030F
By Region: Market Size & Forecast (2020–2030F)
North America
(U.S. and Canada), By Value (USD Million), 2020–2030F; Y-o-Y Growth (%) 2021–2030F
Latin America
(Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million), 2020–2030F; Y-o-Y Growth (%) 2021–2030F
Europe
(Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million), 2020–2030F; Y-o-Y Growth (%) 2021–2030F
Asia-Pacific
(China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), By Value (USD Million), 2020–2030F; Y-o-Y Growth (%) 2021–2030F
Middle East & Africa
(Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), By Value (USD Million), 2020–2030F; Y-o-Y Growth (%) 2021–2030F
Each Company Profile Covers:
Company Overview | Company Total Revenue (Financials) | Market Potential | Global Presence | Key Performance Indicators | SWOT Analysis | Product Launch & Development
Pfizer Inc.
Johnson & Johnson
GlaxoSmithKline Inc.
Sanofi
Serum Institute of India
Gilead Sciences Inc.
F. Hoffmann-La Roche Ltd.
Merck KGaA
Janssen Pharmaceuticals Inc.
Other Prominent Players
(This section includes strategic insights, investment opportunities, and future roadmap for stakeholders.)
Select License Type